Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
Boehringer Ingelheim
AstraZeneca
Colorcon
Express Scripts
Moodys

Last Updated: November 29, 2021

DrugPatentWatch Database Preview

Patent: 10,314,921

➤ Subscribe for complete access

« Back to Dashboard

Summary for Patent: 10,314,921
Title:Antibody-drug-conjugate and its use for the treatment of cancer
Abstract: The present invention relates to an antibody-drug-conjugate. From one aspect, the invention relates to an antibody-drug-conjugate comprising an antibody capable of binding to a Target, said antibody being conjugated to at least one drug selected from derivatives of dolastatin 10 and auristatins. The invention also comprises method of treatment and the use of said antibody-drug-conjugate for the treatment of cancer.
Inventor(s): Rilatt; Ian (Castres, FR), Perez; Michel (Castres, FR), Goetsch; Liliane (Ayze, FR), Broussas; Matthieu (Seyssel, FR), Beau-Larvor; Charlotte (Jonzier Epagny, FR), Haeuw; Jean-Francois (Beaumont, FR), Lamothe; Marie (Montredon Labessonnie, FR)
Assignee: PIERRE FABRE MEDICAMENT (Boulogne-Billancourt, FR)
Application Number:15/306,404
Patent Claims:see list of patent claims

Details for Patent 10,314,921

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Genentech, Inc. HERCEPTIN trastuzumab For Injection 103792 1998-09-25 ⤷  Try it Free 2034-04-25
Genentech, Inc. HERCEPTIN trastuzumab For Injection 103792 2017-02-10 ⤷  Try it Free 2034-04-25
Genentech, Inc. PERJETA pertuzumab Injection 125409 2012-06-08 ⤷  Try it Free 2034-04-25
Genentech, Inc. HERCEPTIN HYLECTA trastuzumab and hyaluronidase-oysk Injection 761106 2019-02-28 ⤷  Try it Free 2034-04-25
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School
Merck
McKinsey
Moodys
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.